XLON
CTHT
Market cap89mUSD
Oct 30, Last price
120.00GBP
1D
0.00%
1Q
-16.67%
Jan 2017
15.52%
IPO
18.23%
Name
Bellevue Healthcare Trust PLC
Chart & performance
P/E
—
P/B
0.09
EPS
—
Vol. 1Y
23.65%
Shs. 5Y
-16.15%
Rev. 5Y
11.17%
Div Yld LY
2.25%
Div Yld TTM
4.39%
Revenues
-85m
L-43.10%
Net income
-52m
L
CFO
-2m
L-71.92%
Dividend
Aug 27, 20262.565 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CT Healthcare Trust Plc is a real estate investment trust, which engages in the provision of shareholders with capital growth and income over the long term. The company was founded on October 7, 2016 and is headquartered in London, the United Kingdom.
Key people
Independent Non-Executive Chairman of the Board · since 2025
Non-Executive Independent Director · since 2025
Senior Non-Executive Independent Director · since 2020
Non-Executive Independent Director · since 2025
Tony Young
Non-Executive Independent Director · since 2020
IPO date
Dec 02, 2016
Employees
0
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
4TH FLOOR 46-48 JAMES STREET
LONDON, LND W1U 1EZ
GB
LONDON, LND W1U 1EZ
GB
Previous name
BELLEVUE HEALTHCARE TRUST PLC
Previous name
BB HEALTHCARE TRUST PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑11 | 2024‑11 | 2023‑11 | 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||